News
Health Canada approves SC rituximab for CLL
- Author:
- HT Staff
Health Canada has approved a subcutaneous (SC) formulation of rituximab (Rituxan®) to treat patients with chronic lymphocytic leukemia (CLL). The...
News
Ponatinib efficacy maintained despite dose reductions
- Author:
- HT Staff
Final results from the phase 2 PACE trial suggest dose reductions did not have an effect on the efficacy of ponatinib in patients with chronic...
News
Kids may have higher rate of AdV infection after HSCT
- Author:
- HT Staff
LISBON—Results of a large study revealed a higher incidence of adenovirus (AdV) infection after allogeneic hematopoietic stem cell transplant (...
News
AdV viral burden linked to mortality in kids
- Author:
- HT Staff
LISBON—Data from the AdVance study revealed a “strong correlation” between adenovirus (AdV) viral load and mortality in pediatric recipients of...
News
FDA releases updates on BIA-ALCL
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has released new information on breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL)....
News
FDA approves BV plus chemo for untreated cHL
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has approved brentuximab vedotin (ADCETRIS) in combination with chemotherapy for adults with previously...
News
Manufactured graft deemed safe in blood cancer patients
- Author:
- HT Staff
LISBON—Phase 1 results suggest a programmed cellular therapy is safe for use in patients with hematologic malignancies. The therapy, ProTmune, is...
News
Severe anemia in pregnancy may double risk of death
- Author:
- HT Staff
Pregnant women with severe anemia are twice as likely as those without it to die during or shortly after pregnancy, according to research...
News
Drug receives orphan designation for CTCL
- Author:
- HT Staff
The US Food and Drug Administration (FDA) has granted orphan drug designation to TTI-621 for the treatment of cutaneous T-cell lymphoma (CTCL)....
News
GPS consolidation may prolong PFS after ASCT
- Author:
- HT Staff
LISBON—Post-transplant therapy including galinpepimut-S (GPS) may prolong progression-free survival (PFS) in patients with high-risk multiple...
News
Antibody protects mice from malaria infection
- Author:
- HT Staff
A human antibody can protect mice from infection with the malaria parasite Plasmodium falciparum, according to research published in Nature...
News
EHRA releases new guide for NOAC use
- Author:
- HT Staff
The European Heart Rhythm Association (EHRA) has released a new version of its “practical guide” for the use of non-vitamin K antagonist oral...
News
AML patients may fare better at NCI centers
- Author:
- HT Staff
New research suggests patients with acute myeloid leukemia (AML) may have a lower risk of early mortality if they receive treatment at a National...
News
Aspirin appears comparable to rivaroxaban for VTE
- Author:
- HT Staff
Aspirin seems to be as effective as rivaroxaban for preventing venous thromboembolism (VTE) after total hip or knee replacement, according to...
News
How US healthcare compares to other countries
- Author:
- HT Staff
The US has similar healthcare utilization as other high-income countries but spends more and tends to have worse health outcomes, according to a...